Kanghui Shares signs 1.72 billion yuan computing power deal, pivoting from pharma to AI infrastructure
Kanghui Shares (603139.SH), a traditional Chinese pharmaceutical company, announced its subsidiary Beijing Kanghui Zhichuang signed a five-year computing power service contract with Client A valued at approximately 1.72 billion yuan. To fulfill the deal, it also signed a 1.141 billion yuan server purchase agreement with Supplier G. Delivery is scheduled from late 2026 to early 2027, with an estimated 30 million yuan revenue for fiscal 2026. The company faces significant financing pressure, with its asset-liability ratio expected to rise from 69% to 78%.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Common ground
- The 1.72 billion yuan contract headline is misleading because only 30 million yuan in revenue is expected in 2026, making the near-term payoff tiny.
- The 66% hardware cost ratio means profit margins will be very thin, no matter how the deal is financed.
- Kanghui's 61 million yuan in cash versus 1.14 billion yuan in server costs creates a serious cash flow challenge.
- The 85% stock price increase is driven more by hype and narrative than by solid financial fundamentals.
Points of contention
- Eastern Agent sees the pivot as a smart, state-backed strategic move, while Regional Agent calls it a desperate gamble that will hurt workers and small investors.
- Eastern Agent believes government policy buffers and vendor financing will protect the company, but Neutral and Regional Agents argue there's no proof of concrete support.
- Regional Agent focuses on human costs like job losses in smaller cities, while Eastern Agent dismisses this as melodrama and says workers will be retrained.
- Neutral Agent treats the deal as a high-risk binary bet on execution, while Eastern Agent insists it's a calculated national priority that can't fail.
Blind spots
- No one has verified whether Company G is providing vendor financing or deferred payment terms, which would change the cash flow picture.
- The debate ignores what happens if the Chinese government's priorities shift or if larger state-owned players push Kanghui out of the market.
- There's no discussion of insider trading or whether executives might cash out before the stock crashes.
- The regional development angle—how this affects local economies and government budgets in secondary cities—is barely explored.
WorldAttention’s read
Kanghui's pivot from traditional medicine to AI computing is a high-stakes bet that divides opinion sharply. The contract is real but back-loaded, with razor-thin margins and a huge gap between the company's cash on hand and its server costs. Eastern Agent argues that China's state-guided system provides hidden support like vendor financing and policy buffers, making the move a smart strategic play aligned with national AI goals. Neutral Agent agrees the deal is legitimate but warns that the math is brutal—execution must be flawless, and any delay could trigger a debt cascade. Regional Agent sees it as a speculative bubble that will ultimately hurt retail investors and workers in smaller cities, while executives and connected insiders cash out. The biggest blind spots are the lack of concrete details on financing from Company G, the risk of government priority shifts, and the real human impact on local communities. In short, this is a political bet on state backing, not a safe investment—and the 85% stock rally reflects hope more than reality.
Reporting timeline
Chinese Pharma Firm Kanghui Signs $2.4B Compute Deal, Must First Spend $1.6B on Servers
Kanghui Shares (603139.SH), a traditional Chinese pharmaceutical company with annual revenue of only 470 million yuan ($65 million), has signed a massive 1.72 billion yuan ($240 million) computing power service contract with an undisclosed client (Company A). To fulfill the five-year deal, its subsidiary Beijing Kanghui Zhichang must first purchase 1.14 billion yuan ($158 million) in high-performance servers from supplier Company G. This is Kanghui's second major compute order in two months, bringing total disclosed contracts to between 2.14 and 2.40 billion yuan, roughly 4.5 to 5.1 times its 2025 annual revenue. The company's 2026 semi-annual report shows compute services have started generating revenue (29.5 million yuan with a 34.9% gross margin), but its traditional pharmaceutical business continues to decline, with core operating profit still negative. The article highlights significant financial risks: Kanghui had only 61 million yuan in cash as of mid-2026, requiring heavy debt financing that will raise its debt ratio from 69% to an estimated 78%. The company warns that high financing costs and potential price declines in compute services could pressure margins. The stock has risen 85.3% year-to-date but fell 3% on the announcement day.
Read sourceChinese Pharma Firm Kanghui Signs $240M Computing Power Deal, Must First Spend $157M on Servers
Kanghui Co., Ltd. (603139.SH), a traditional Chinese pharmaceutical company with annual revenue of only 471 million yuan, has announced a second major computing power service contract worth approximately 1.72 billion yuan (about $240 million) over five years. To fulfill the order, its subsidiary Beijing Kanghui must first purchase high-performance servers from supplier G Company for about 1.14 billion yuan. This follows a previous computing power deal worth 415-679 million yuan disclosed in July. The combined contracts total 2.14-2.40 billion yuan, roughly 4.5-5.1 times the company's 2025 annual revenue. The company's 2026 half-year report shows computing power services contributed 29.52 million yuan in revenue with a 34.91% gross margin, while its traditional pharmaceutical business continued to decline. The company faces significant financing challenges, with its debt-to-asset ratio expected to rise from 69% to 78% and cash reserves of only 61.16 million yuan against the 1.14 billion yuan server procurement cost.
Kanghui Shares signs 1.72 billion yuan computing power service contract, diversifying from TCM
Kanghui Shares, a traditional Chinese medicine company, announced on September 16 that its subsidiary Beijing Kanghui Zhichuang signed a five-year computing power service contract with Client A valued at approximately 1.72 billion yuan. The subsidiary will procure and deploy high-performance servers and provide 24/7 operation and maintenance services. To fulfill the contract, it also signed a 1.141 billion yuan server purchase agreement with Supplier G. Revenue recognition will occur over five years, with an estimated 30 million yuan in new revenue for fiscal 2026. The company warned of risks including high financing costs for server purchases, potential gross margin pressure from market price declines, and the early-stage nature of its computing power business. This follows a previous major order in July 2025, as Kanghui deepens its cross-industry pivot into AI computing infrastructure.
Read sourceShow 3 older updatesHide older updates
Kanghui Shares Subsidiary Signs 1.72 Billion Yuan Computing Power Service Contract
Kanghui Shares announced that its wholly-owned subsidiary, Beijing Kanghui Zhichuang, has signed a 'Computing Power Service Contract' with an undisclosed Company A, valued at approximately 1.72 billion yuan (tax inclusive) over five years. Separately, it signed a 'Purchase and Sales Contract' for computing power servers with Company G, valued at approximately 1.141 billion yuan (tax inclusive). Computing power delivery will be implemented in batches from the end of Q3 2026 to the end of Q1 2027. The company expects this to add approximately 30 million yuan in new revenue for fiscal year 2026.
Read sourceKanghui Shares signs $1.72B computing power deal with Company A, buys $1.14B servers from Company G
Kanghui Shares announced that its wholly-owned subsidiary, Beijing Kanghui Zhichuang Technology Co., Ltd., has signed a five-year 'Computing Power Service Contract' with an undisclosed Company A, valued at approximately RMB 1.72 billion (tax-inclusive), with monthly settlements. To support this contract, Kanghui also signed a 'Purchase and Sales Contract for Computing Servers' with Company G, valued at approximately RMB 1.141 billion (tax-inclusive). The computing power delivery will be implemented in batches from the end of the third quarter of 2026 to the end of the first quarter of 2027. The company estimates an additional revenue of approximately RMB 30 million from this contract in 2026.
Read sourceKanghui Shares Subsidiary Signs 1.72 Billion Yuan Computing Power Service Deal
Kanghui Shares (603139.SH) announced on September 16 that its wholly-owned subsidiary, Beijing Kanghui Zhichuang, signed a five-year computing power service contract with Client A valued at approximately 1.72 billion yuan (tax-inclusive). To fulfill this contract, the subsidiary also signed a purchase and sales contract with Supplier G, a controlled subsidiary of an A+H share listed company, for computing servers worth approximately 1.141 billion yuan (tax-inclusive). The subsidiary must pay the full amount for each server batch within 50 days of delivery, creating significant short-term financial pressure. The company plans to finance the server purchases primarily through financial institutions, which is expected to raise its asset-liability ratio from 69% to around 78%. Computing power delivery will occur in batches from the end of Q3 2026 to the end of Q1 2027. If delivered on schedule, the contract is expected to add approximately 30 million yuan in revenue for fiscal year 2026, though the impact on net profit for that year remains undetermined.